|
Molecular function
|
| Structural constituent of muscle |
1.31E−14 |
| Titin binding |
2.31E−07 |
| Cytoskeletal binding |
2.32E−07 |
| Actin binding |
1.52E−05 |
| Actinin binding |
2.08E−04 |
|
|
|
Biological process
|
| Muscle system process |
3.73E−18 |
| Muscle contraction |
2.63E−16 |
| Striated muscle contraction |
6.13E−11 |
| Muscle structure development |
2.83E−09 |
| Muscle tissue development |
7.37E−09 |
|
|
|
Cellular component
|
| Myofibril |
5.07E−33 |
| Contractile fiber |
8.10E−33 |
| Sarcomere |
1.12E−32 |
| I band |
9.52E−24 |
|
|
|
Mouse phenotype
|
| Abnormal muscle contractility |
2.71E−06 |
| Impaired skeletal contractility |
3.09E−05 |
| Impaired muscle contractility |
3.32E−05 |
| Abnormal skeletal muscle morphology |
1.05E−04 |
| Abnormal muscle physiology |
1.10E−04 |
|
|
|
Pathway
|
| Striated muscle contraction |
7.38E−07 |
| Genes involved in striated muscle contraction |
9.19E−07 |
| Genes involved in muscle contraction |
3.02E−05 |
| Diurnally regulated genes with circadian orthologs |
1.46E−03 |
| Genes involved in glycogen breakdown |
4.71E−03 |
|
|
|
Interactions
|
| Titin (TTN) |
6.05E−09 |
| Titin-cap (TCAP) |
1.82E−03 |
| Nebulin (NEB) |
3.29E−03 |
| Myozenin 3 (MYOZ3) |
4.03E−03 |
| Tripartite motif-containing 63 (TRIM63) |
7.51E−03 |
